Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for PATZ1_KLF4
Z-value: 2.88
Motif logo
Transcription factors associated with PATZ1_KLF4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
|
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| KLF4 | hg19_v2_chr9_-_110251836_110251927 | -0.20 | 4.0e-01 | Click! |
| PATZ1 | hg19_v2_chr22_-_31741757_31741770 | 0.15 | 5.4e-01 | Click! |
Activity profile of PATZ1_KLF4 motif
Sorted Z-values of PATZ1_KLF4 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr11_-_568369 | 12.48 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
| chr8_+_145691411 | 10.55 |
ENST00000301332.2
|
KIFC2
|
kinesin family member C2 |
| chr8_-_145691031 | 9.06 |
ENST00000424149.2
ENST00000530637.1 ENST00000306145.5 |
CYHR1
|
cysteine/histidine-rich 1 |
| chr9_+_130922537 | 8.92 |
ENST00000372994.1
|
C9orf16
|
chromosome 9 open reading frame 16 |
| chr11_-_560703 | 8.76 |
ENST00000441853.1
ENST00000329451.3 |
C11orf35
|
chromosome 11 open reading frame 35 |
| chr19_-_10047219 | 8.45 |
ENST00000264833.4
|
OLFM2
|
olfactomedin 2 |
| chr9_+_130911723 | 8.09 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
| chr16_-_89268070 | 8.00 |
ENST00000562855.2
|
SLC22A31
|
solute carrier family 22, member 31 |
| chr17_-_76356148 | 7.93 |
ENST00000587578.1
ENST00000330871.2 |
SOCS3
|
suppressor of cytokine signaling 3 |
| chr11_+_64008525 | 7.90 |
ENST00000449942.2
|
FKBP2
|
FK506 binding protein 2, 13kDa |
| chr16_+_1203194 | 7.65 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
| chr7_+_5322561 | 7.53 |
ENST00000396872.3
ENST00000444741.1 ENST00000297195.4 ENST00000406453.3 |
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4 |
| chr19_+_39897453 | 7.07 |
ENST00000597629.1
ENST00000248673.3 ENST00000594045.1 ENST00000594442.1 |
ZFP36
|
ZFP36 ring finger protein |
| chr19_-_39226045 | 7.04 |
ENST00000597987.1
ENST00000595177.1 |
CAPN12
|
calpain 12 |
| chr19_+_47778119 | 6.94 |
ENST00000552360.2
|
PRR24
|
proline rich 24 |
| chr14_-_21566731 | 6.79 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr19_-_1863567 | 6.61 |
ENST00000250916.4
|
KLF16
|
Kruppel-like factor 16 |
| chr9_+_140317802 | 6.59 |
ENST00000341349.2
ENST00000392815.2 |
NOXA1
|
NADPH oxidase activator 1 |
| chr9_+_130911770 | 6.48 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
| chr8_-_144651024 | 6.34 |
ENST00000524906.1
ENST00000532862.1 ENST00000534459.1 |
MROH6
|
maestro heat-like repeat family member 6 |
| chr16_+_2039946 | 6.28 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
| chr11_+_64009072 | 6.27 |
ENST00000535135.1
ENST00000394540.3 |
FKBP2
|
FK506 binding protein 2, 13kDa |
| chr11_+_64073022 | 6.07 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
| chr11_+_369804 | 5.99 |
ENST00000329962.6
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
| chr20_-_3154162 | 5.96 |
ENST00000360342.3
|
LZTS3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
| chr7_-_149470540 | 5.91 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
| chr14_+_105559784 | 5.90 |
ENST00000548104.1
|
RP11-44N21.1
|
RP11-44N21.1 |
| chr12_+_57916466 | 5.86 |
ENST00000355673.3
|
MBD6
|
methyl-CpG binding domain protein 6 |
| chr2_+_220306745 | 5.84 |
ENST00000431523.1
ENST00000396698.1 ENST00000396695.2 |
SPEG
|
SPEG complex locus |
| chr6_+_37137939 | 5.79 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr16_+_29911666 | 5.64 |
ENST00000563177.1
ENST00000483405.1 |
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
| chr1_+_37940153 | 5.61 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
| chr1_-_3528034 | 5.60 |
ENST00000356575.4
|
MEGF6
|
multiple EGF-like-domains 6 |
| chr11_+_560956 | 5.59 |
ENST00000397582.3
ENST00000344375.4 ENST00000397583.3 |
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
| chr7_-_1499123 | 5.54 |
ENST00000297508.7
|
MICALL2
|
MICAL-like 2 |
| chr8_-_144923112 | 5.42 |
ENST00000442628.2
|
NRBP2
|
nuclear receptor binding protein 2 |
| chr16_-_89768097 | 5.33 |
ENST00000289805.5
ENST00000335360.7 |
SPATA2L
|
spermatogenesis associated 2-like |
| chr19_+_6373482 | 5.30 |
ENST00000596657.1
|
ALKBH7
|
alkB, alkylation repair homolog 7 (E. coli) |
| chr16_+_67198683 | 5.28 |
ENST00000517685.1
ENST00000521374.1 ENST00000584272.1 |
HSF4
|
heat shock transcription factor 4 |
| chr7_+_97910962 | 5.23 |
ENST00000539286.1
|
BRI3
|
brain protein I3 |
| chr1_-_32801825 | 5.19 |
ENST00000329421.7
|
MARCKSL1
|
MARCKS-like 1 |
| chr1_-_160068465 | 5.14 |
ENST00000314485.7
ENST00000368086.1 |
IGSF8
|
immunoglobulin superfamily, member 8 |
| chr19_+_6373715 | 5.14 |
ENST00000599849.1
|
ALKBH7
|
alkB, alkylation repair homolog 7 (E. coli) |
| chr16_+_2563871 | 5.12 |
ENST00000330398.4
ENST00000568562.1 ENST00000569317.1 |
ATP6V0C
ATP6C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c Uncharacterized protein |
| chr19_+_41284121 | 5.12 |
ENST00000594800.1
ENST00000357052.2 ENST00000602173.1 |
RAB4B
|
RAB4B, member RAS oncogene family |
| chr19_-_663277 | 5.11 |
ENST00000292363.5
|
RNF126
|
ring finger protein 126 |
| chr19_-_38878632 | 5.11 |
ENST00000586599.1
ENST00000334928.6 ENST00000587676.1 |
GGN
|
gametogenetin |
| chr14_-_100625932 | 5.08 |
ENST00000553834.1
|
DEGS2
|
delta(4)-desaturase, sphingolipid 2 |
| chr1_-_11714700 | 5.03 |
ENST00000354287.4
|
FBXO2
|
F-box protein 2 |
| chr13_-_114018400 | 5.01 |
ENST00000375430.4
ENST00000375431.4 |
GRTP1
|
growth hormone regulated TBC protein 1 |
| chr7_-_149470297 | 5.00 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
| chr19_-_8675559 | 4.96 |
ENST00000597188.1
|
ADAMTS10
|
ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
| chr19_-_291365 | 4.93 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr13_-_110438914 | 4.92 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr1_+_3689325 | 4.90 |
ENST00000444870.2
ENST00000452264.1 |
SMIM1
|
small integral membrane protein 1 (Vel blood group) |
| chr16_+_88519669 | 4.90 |
ENST00000319555.3
|
ZFPM1
|
zinc finger protein, FOG family member 1 |
| chr1_+_955448 | 4.89 |
ENST00000379370.2
|
AGRN
|
agrin |
| chr19_+_56111680 | 4.80 |
ENST00000301073.3
|
ZNF524
|
zinc finger protein 524 |
| chr19_+_56652556 | 4.79 |
ENST00000337080.3
|
ZNF444
|
zinc finger protein 444 |
| chr22_-_50689640 | 4.76 |
ENST00000448072.1
|
HDAC10
|
histone deacetylase 10 |
| chr11_+_64008443 | 4.71 |
ENST00000309366.4
|
FKBP2
|
FK506 binding protein 2, 13kDa |
| chr16_+_29911864 | 4.71 |
ENST00000308748.5
|
ASPHD1
|
aspartate beta-hydroxylase domain containing 1 |
| chr22_-_50970506 | 4.70 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr11_+_2923423 | 4.65 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr19_+_2977444 | 4.65 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
| chr7_-_1498962 | 4.64 |
ENST00000405088.4
|
MICALL2
|
MICAL-like 2 |
| chr9_+_140500087 | 4.64 |
ENST00000371421.4
|
ARRDC1
|
arrestin domain containing 1 |
| chr12_+_52445191 | 4.63 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr16_-_8962853 | 4.57 |
ENST00000565287.1
ENST00000311052.5 |
CARHSP1
|
calcium regulated heat stable protein 1, 24kDa |
| chr19_+_36266417 | 4.54 |
ENST00000378944.5
ENST00000007510.4 |
ARHGAP33
|
Rho GTPase activating protein 33 |
| chr5_+_176513868 | 4.51 |
ENST00000292408.4
|
FGFR4
|
fibroblast growth factor receptor 4 |
| chr16_-_325910 | 4.51 |
ENST00000359740.5
ENST00000316163.5 ENST00000431291.2 ENST00000397770.3 ENST00000397768.3 |
RGS11
|
regulator of G-protein signaling 11 |
| chrX_+_152990302 | 4.49 |
ENST00000218104.3
|
ABCD1
|
ATP-binding cassette, sub-family D (ALD), member 1 |
| chr9_+_136325089 | 4.49 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
| chr17_-_79791118 | 4.49 |
ENST00000576431.1
ENST00000575061.1 ENST00000455127.2 ENST00000572645.1 ENST00000538396.1 ENST00000573478.1 |
FAM195B
|
family with sequence similarity 195, member B |
| chr19_-_913160 | 4.48 |
ENST00000361574.5
ENST00000587975.1 |
R3HDM4
|
R3H domain containing 4 |
| chr11_+_2923619 | 4.39 |
ENST00000380574.1
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr16_-_2246436 | 4.33 |
ENST00000343516.6
|
CASKIN1
|
CASK interacting protein 1 |
| chr14_-_21567009 | 4.31 |
ENST00000556174.1
ENST00000554478.1 ENST00000553980.1 ENST00000421093.2 |
ZNF219
|
zinc finger protein 219 |
| chr20_+_388791 | 4.29 |
ENST00000441733.1
ENST00000353660.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
| chr19_-_460996 | 4.27 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
| chr17_+_81037473 | 4.26 |
ENST00000320095.7
|
METRNL
|
meteorin, glial cell differentiation regulator-like |
| chr22_-_30783075 | 4.24 |
ENST00000215798.6
|
RNF215
|
ring finger protein 215 |
| chr11_-_17565947 | 4.24 |
ENST00000527020.1
ENST00000318024.4 |
USH1C
|
Usher syndrome 1C (autosomal recessive, severe) |
| chr12_+_58148842 | 4.24 |
ENST00000266643.5
|
MARCH9
|
membrane-associated ring finger (C3HC4) 9 |
| chr4_+_74735102 | 4.21 |
ENST00000395761.3
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
| chr17_+_77020325 | 4.21 |
ENST00000311661.4
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr19_-_4670345 | 4.21 |
ENST00000599630.1
ENST00000262947.3 |
C19orf10
|
chromosome 19 open reading frame 10 |
| chr21_-_45759250 | 4.20 |
ENST00000397956.3
ENST00000339818.4 ENST00000325223.7 |
C21orf2
|
chromosome 21 open reading frame 2 |
| chr8_+_145490549 | 4.19 |
ENST00000340695.2
|
SCXA
|
scleraxis homolog A (mouse) |
| chr5_+_176513895 | 4.18 |
ENST00000503708.1
ENST00000393648.2 ENST00000514472.1 ENST00000502906.1 ENST00000292410.3 ENST00000510911.1 |
FGFR4
|
fibroblast growth factor receptor 4 |
| chr22_-_50689786 | 4.17 |
ENST00000216271.5
|
HDAC10
|
histone deacetylase 10 |
| chr19_-_14201776 | 4.14 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr20_-_17662705 | 4.11 |
ENST00000455029.2
|
RRBP1
|
ribosome binding protein 1 |
| chr19_+_45349630 | 4.10 |
ENST00000252483.5
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
| chr22_+_29279552 | 4.10 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
| chr19_+_16435625 | 4.08 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr19_+_51152702 | 4.07 |
ENST00000425202.1
|
C19orf81
|
chromosome 19 open reading frame 81 |
| chr12_+_57916584 | 4.07 |
ENST00000546632.1
ENST00000549623.1 ENST00000431731.2 |
MBD6
|
methyl-CpG binding domain protein 6 |
| chr19_-_3029011 | 4.06 |
ENST00000590536.1
ENST00000587137.1 ENST00000455444.2 ENST00000262953.6 |
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
| chr11_+_2923499 | 4.02 |
ENST00000449793.2
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr19_+_56652686 | 4.00 |
ENST00000592949.1
|
ZNF444
|
zinc finger protein 444 |
| chr12_-_53574376 | 4.00 |
ENST00000267085.4
ENST00000379850.3 ENST00000379846.1 ENST00000424990.1 |
CSAD
|
cysteine sulfinic acid decarboxylase |
| chr6_-_33285505 | 4.00 |
ENST00000431845.2
|
ZBTB22
|
zinc finger and BTB domain containing 22 |
| chr19_-_46272462 | 3.99 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
| chr19_-_54974894 | 3.96 |
ENST00000333834.4
|
LENG9
|
leukocyte receptor cluster (LRC) member 9 |
| chr1_+_11714914 | 3.95 |
ENST00000425796.1
ENST00000376770.1 ENST00000376768.1 ENST00000251547.5 ENST00000376760.1 ENST00000376762.4 |
FBXO44
|
F-box protein 44 |
| chr7_-_99774945 | 3.94 |
ENST00000292377.2
|
GPC2
|
glypican 2 |
| chr20_-_17662878 | 3.92 |
ENST00000377813.1
ENST00000377807.2 ENST00000360807.4 ENST00000398782.2 |
RRBP1
|
ribosome binding protein 1 |
| chr16_+_29817841 | 3.87 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr22_+_50354104 | 3.84 |
ENST00000360612.4
|
PIM3
|
pim-3 oncogene |
| chr16_+_770975 | 3.83 |
ENST00000569529.1
ENST00000564000.1 ENST00000219535.3 |
FAM173A
|
family with sequence similarity 173, member A |
| chr19_-_18392422 | 3.82 |
ENST00000252818.3
|
JUND
|
jun D proto-oncogene |
| chr11_+_64002292 | 3.78 |
ENST00000426086.2
|
VEGFB
|
vascular endothelial growth factor B |
| chr22_-_50968419 | 3.78 |
ENST00000425169.1
ENST00000395680.1 ENST00000395681.1 ENST00000395678.3 ENST00000252029.3 |
TYMP
|
thymidine phosphorylase |
| chr16_+_14396121 | 3.77 |
ENST00000570945.1
|
RP11-65J21.3
|
RP11-65J21.3 |
| chr1_+_45140360 | 3.73 |
ENST00000418644.1
ENST00000458657.2 ENST00000441519.1 ENST00000535358.1 ENST00000445071.1 |
C1orf228
|
chromosome 1 open reading frame 228 |
| chr5_-_177659761 | 3.73 |
ENST00000308158.5
|
PHYKPL
|
5-phosphohydroxy-L-lysine phospho-lyase |
| chr8_+_144349606 | 3.72 |
ENST00000521682.1
ENST00000340042.1 |
GLI4
|
GLI family zinc finger 4 |
| chr16_-_30022735 | 3.71 |
ENST00000564944.1
|
DOC2A
|
double C2-like domains, alpha |
| chr19_+_45973120 | 3.71 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr11_-_62389621 | 3.70 |
ENST00000531383.1
ENST00000265471.5 |
B3GAT3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
| chr22_-_50946113 | 3.66 |
ENST00000216080.5
ENST00000474879.2 ENST00000380796.3 |
LMF2
|
lipase maturation factor 2 |
| chrX_-_153775426 | 3.65 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr2_+_219264466 | 3.65 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr20_-_23618582 | 3.65 |
ENST00000398411.1
ENST00000376925.3 |
CST3
|
cystatin C |
| chr16_-_1020954 | 3.62 |
ENST00000543238.1
ENST00000539379.1 ENST00000399843.2 ENST00000262301.11 |
LMF1
|
lipase maturation factor 1 |
| chr11_+_57227981 | 3.61 |
ENST00000335099.3
|
RTN4RL2
|
reticulon 4 receptor-like 2 |
| chr12_+_133066137 | 3.61 |
ENST00000434748.2
|
FBRSL1
|
fibrosin-like 1 |
| chr7_+_73082152 | 3.60 |
ENST00000324941.4
ENST00000451519.1 |
VPS37D
|
vacuolar protein sorting 37 homolog D (S. cerevisiae) |
| chr19_+_56652643 | 3.59 |
ENST00000586123.1
|
ZNF444
|
zinc finger protein 444 |
| chr22_-_50970566 | 3.59 |
ENST00000405135.1
ENST00000401779.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr8_+_145064233 | 3.58 |
ENST00000529301.1
ENST00000395068.4 |
GRINA
|
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
| chr16_-_1993260 | 3.58 |
ENST00000361871.3
|
MSRB1
|
methionine sulfoxide reductase B1 |
| chr16_-_88717482 | 3.57 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
| chr19_+_35491174 | 3.56 |
ENST00000317991.5
ENST00000504615.2 |
GRAMD1A
|
GRAM domain containing 1A |
| chr20_+_48807351 | 3.54 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
| chr22_+_38004832 | 3.54 |
ENST00000405147.3
ENST00000429218.1 ENST00000325180.8 ENST00000337437.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
| chr9_+_139886846 | 3.52 |
ENST00000371620.3
|
C9orf142
|
chromosome 9 open reading frame 142 |
| chr7_+_97910981 | 3.51 |
ENST00000297290.3
|
BRI3
|
brain protein I3 |
| chr16_-_88923285 | 3.51 |
ENST00000542788.1
ENST00000569433.1 ENST00000268695.5 ENST00000568311.1 |
GALNS
|
galactosamine (N-acetyl)-6-sulfate sulfatase |
| chr22_+_29469012 | 3.50 |
ENST00000400335.4
ENST00000400338.2 |
KREMEN1
|
kringle containing transmembrane protein 1 |
| chr19_+_45504688 | 3.50 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
| chr11_+_289155 | 3.49 |
ENST00000409655.1
|
ATHL1
|
ATH1, acid trehalase-like 1 (yeast) |
| chr19_+_1905365 | 3.49 |
ENST00000329478.2
ENST00000602400.1 ENST00000409472.1 |
ADAT3
SCAMP4
|
adenosine deaminase, tRNA-specific 3 secretory carrier membrane protein 4 |
| chr19_+_48673949 | 3.49 |
ENST00000328759.7
|
C19orf68
|
chromosome 19 open reading frame 68 |
| chr9_-_96717654 | 3.48 |
ENST00000253968.6
|
BARX1
|
BARX homeobox 1 |
| chr7_-_73038822 | 3.48 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
| chr19_+_589893 | 3.47 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| chr19_+_2096868 | 3.47 |
ENST00000395296.1
ENST00000395301.3 |
IZUMO4
|
IZUMO family member 4 |
| chr8_+_145064215 | 3.47 |
ENST00000313269.5
|
GRINA
|
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
| chr9_-_35115836 | 3.47 |
ENST00000378566.1
ENST00000378554.2 ENST00000322813.5 |
FAM214B
|
family with sequence similarity 214, member B |
| chr19_+_11466167 | 3.45 |
ENST00000591608.1
|
DKFZP761J1410
|
Lipid phosphate phosphatase-related protein type 2 |
| chr16_+_2564254 | 3.44 |
ENST00000565223.1
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
| chr16_-_11350036 | 3.44 |
ENST00000332029.2
|
SOCS1
|
suppressor of cytokine signaling 1 |
| chr19_-_36545128 | 3.43 |
ENST00000538849.1
|
THAP8
|
THAP domain containing 8 |
| chr14_-_105647606 | 3.43 |
ENST00000392568.2
|
NUDT14
|
nudix (nucleoside diphosphate linked moiety X)-type motif 14 |
| chr20_+_34203794 | 3.42 |
ENST00000374273.3
|
SPAG4
|
sperm associated antigen 4 |
| chr11_-_62380199 | 3.42 |
ENST00000419857.1
ENST00000394773.2 |
EML3
|
echinoderm microtubule associated protein like 3 |
| chr10_+_135192695 | 3.42 |
ENST00000368539.4
ENST00000278060.5 ENST00000357296.3 |
PAOX
|
polyamine oxidase (exo-N4-amino) |
| chr11_-_67771513 | 3.41 |
ENST00000227471.2
|
UNC93B1
|
unc-93 homolog B1 (C. elegans) |
| chr7_-_73038867 | 3.41 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
| chr11_+_289110 | 3.41 |
ENST00000409548.2
|
ATHL1
|
ATH1, acid trehalase-like 1 (yeast) |
| chr19_+_36266433 | 3.40 |
ENST00000314737.5
|
ARHGAP33
|
Rho GTPase activating protein 33 |
| chr1_-_3447967 | 3.40 |
ENST00000294599.4
|
MEGF6
|
multiple EGF-like-domains 6 |
| chr21_+_46825032 | 3.40 |
ENST00000400337.2
|
COL18A1
|
collagen, type XVIII, alpha 1 |
| chr1_+_11714425 | 3.40 |
ENST00000251546.4
|
FBXO44
|
F-box protein 44 |
| chr16_-_30022293 | 3.38 |
ENST00000565273.1
ENST00000567332.2 ENST00000350119.4 |
DOC2A
|
double C2-like domains, alpha |
| chr8_-_144679602 | 3.38 |
ENST00000526710.1
|
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
| chr1_+_38273818 | 3.37 |
ENST00000373042.4
|
C1orf122
|
chromosome 1 open reading frame 122 |
| chr16_+_2933209 | 3.37 |
ENST00000293981.6
|
FLYWCH2
|
FLYWCH family member 2 |
| chr3_-_45267760 | 3.36 |
ENST00000503771.1
|
TMEM158
|
transmembrane protein 158 (gene/pseudogene) |
| chr10_+_112257596 | 3.36 |
ENST00000369583.3
|
DUSP5
|
dual specificity phosphatase 5 |
| chr19_+_17581253 | 3.36 |
ENST00000252595.7
ENST00000598424.1 |
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1 |
| chr22_+_50946645 | 3.35 |
ENST00000420993.2
ENST00000395698.3 ENST00000395701.3 ENST00000523045.1 ENST00000299821.11 |
NCAPH2
|
non-SMC condensin II complex, subunit H2 |
| chr19_+_11466062 | 3.35 |
ENST00000251473.5
ENST00000591329.1 ENST00000586380.1 |
DKFZP761J1410
|
Lipid phosphate phosphatase-related protein type 2 |
| chr16_-_1821721 | 3.34 |
ENST00000219302.3
|
NME3
|
NME/NM23 nucleoside diphosphate kinase 3 |
| chrX_-_153095945 | 3.34 |
ENST00000164640.4
|
PDZD4
|
PDZ domain containing 4 |
| chr11_-_805224 | 3.34 |
ENST00000347755.5
|
PIDD
|
p53-induced death domain protein |
| chr11_+_67056755 | 3.34 |
ENST00000511455.2
ENST00000308440.6 |
ANKRD13D
|
ankyrin repeat domain 13 family, member D |
| chr18_+_55102917 | 3.34 |
ENST00000491143.2
|
ONECUT2
|
one cut homeobox 2 |
| chr1_+_6845384 | 3.34 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
| chr8_+_22457100 | 3.34 |
ENST00000409586.3
|
C8orf58
|
chromosome 8 open reading frame 58 |
| chr19_-_14201507 | 3.34 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr19_+_45971246 | 3.33 |
ENST00000585836.1
ENST00000417353.2 ENST00000353609.3 ENST00000591858.1 ENST00000443841.2 ENST00000590335.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr11_-_62389449 | 3.33 |
ENST00000534026.1
|
B3GAT3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
| chr8_+_144679984 | 3.33 |
ENST00000504548.2
ENST00000321385.3 |
TIGD5
|
tigger transposable element derived 5 |
| chrX_+_153607557 | 3.32 |
ENST00000369842.4
ENST00000369835.3 |
EMD
|
emerin |
| chr7_+_2671568 | 3.32 |
ENST00000258796.7
|
TTYH3
|
tweety family member 3 |
| chr12_-_54785054 | 3.32 |
ENST00000352268.6
ENST00000549962.1 |
ZNF385A
|
zinc finger protein 385A |
| chr16_+_2570340 | 3.32 |
ENST00000568263.1
ENST00000293971.6 ENST00000302956.4 ENST00000413459.3 ENST00000566706.1 ENST00000569879.1 |
AMDHD2
|
amidohydrolase domain containing 2 |
| chr9_+_139606983 | 3.32 |
ENST00000371692.4
|
FAM69B
|
family with sequence similarity 69, member B |
| chrX_+_153237740 | 3.31 |
ENST00000369982.4
|
TMEM187
|
transmembrane protein 187 |
| chr12_-_6982442 | 3.30 |
ENST00000523102.1
ENST00000524270.1 ENST00000519357.1 |
SPSB2
|
splA/ryanodine receptor domain and SOCS box containing 2 |
| chr17_+_80376194 | 3.29 |
ENST00000337014.6
|
HEXDC
|
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing |
| chr12_-_125348448 | 3.28 |
ENST00000339570.5
|
SCARB1
|
scavenger receptor class B, member 1 |
| chr19_+_1249869 | 3.28 |
ENST00000591446.2
|
MIDN
|
midnolin |
| chr17_+_80186273 | 3.27 |
ENST00000584689.1
ENST00000392341.1 ENST00000583237.1 |
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3 |
| chr7_+_2443202 | 3.26 |
ENST00000258711.6
|
CHST12
|
carbohydrate (chondroitin 4) sulfotransferase 12 |
| chr17_-_1619568 | 3.26 |
ENST00000571595.1
|
MIR22HG
|
MIR22 host gene (non-protein coding) |
Network of associatons between targets according to the STRING database.
First level regulatory network of PATZ1_KLF4
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 17.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 3.4 | 10.2 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 2.6 | 2.6 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 2.5 | 7.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 2.4 | 2.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 2.4 | 12.1 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 2.2 | 11.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 2.2 | 6.7 | GO:2000625 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 2.0 | 2.0 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 1.9 | 5.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 1.9 | 9.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 1.8 | 5.5 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 1.8 | 7.3 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 1.8 | 7.2 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 1.7 | 10.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 1.7 | 5.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 1.7 | 5.0 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 1.6 | 6.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 1.6 | 1.6 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.6 | 6.4 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 1.6 | 8.0 | GO:1903412 | response to bile acid(GO:1903412) |
| 1.5 | 4.6 | GO:0003192 | mitral valve formation(GO:0003192) |
| 1.5 | 4.5 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 1.5 | 3.0 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 1.5 | 13.1 | GO:0046618 | drug export(GO:0046618) |
| 1.5 | 4.4 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.4 | 11.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 1.4 | 5.7 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 1.4 | 8.6 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.4 | 4.3 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 1.4 | 7.1 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.4 | 5.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 1.4 | 9.5 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 1.3 | 8.0 | GO:0030421 | defecation(GO:0030421) |
| 1.3 | 13.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 1.3 | 5.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 1.3 | 6.5 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.3 | 3.8 | GO:1990575 | mitochondrial L-ornithine transmembrane transport(GO:1990575) |
| 1.3 | 3.8 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 1.3 | 5.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 1.3 | 1.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.3 | 6.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.3 | 3.8 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.2 | 1.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 1.2 | 3.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 1.2 | 3.7 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 1.2 | 6.1 | GO:0003070 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.2 | 3.6 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 1.2 | 2.4 | GO:1901656 | glycoside transport(GO:1901656) |
| 1.2 | 2.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.2 | 4.7 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 1.1 | 4.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.1 | 3.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 1.1 | 1.1 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 1.1 | 6.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.1 | 4.5 | GO:0048687 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 1.1 | 4.5 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 1.1 | 3.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.1 | 3.2 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 1.1 | 2.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 1.1 | 1.1 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
| 1.1 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.0 | 3.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 1.0 | 15.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 1.0 | 9.4 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 1.0 | 3.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.0 | 3.1 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 1.0 | 1.0 | GO:0030220 | platelet formation(GO:0030220) |
| 1.0 | 4.1 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.0 | 5.1 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 1.0 | 3.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 1.0 | 3.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 1.0 | 3.0 | GO:0019516 | lactate oxidation(GO:0019516) |
| 1.0 | 8.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 1.0 | 6.0 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 1.0 | 6.0 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.0 | 5.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 1.0 | 5.9 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.0 | 2.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 1.0 | 1.0 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
| 1.0 | 8.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 1.0 | 5.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.9 | 7.5 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.9 | 3.8 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.9 | 1.9 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.9 | 3.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.9 | 1.9 | GO:0060324 | face development(GO:0060324) |
| 0.9 | 0.9 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.9 | 0.9 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.9 | 6.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.9 | 5.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.9 | 2.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.9 | 7.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.9 | 3.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.9 | 2.7 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.9 | 2.7 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.9 | 3.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.9 | 2.6 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.9 | 5.3 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.9 | 4.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.9 | 4.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.9 | 2.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.9 | 3.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.8 | 1.7 | GO:0072021 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 0.8 | 0.8 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.8 | 3.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.8 | 4.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.8 | 2.5 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.8 | 0.8 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.8 | 10.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.8 | 0.8 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.8 | 2.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.8 | 0.8 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.8 | 2.4 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.8 | 0.8 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.8 | 3.2 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.8 | 4.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.8 | 0.8 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.8 | 0.8 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.8 | 6.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.8 | 1.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.8 | 1.6 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.8 | 3.9 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.8 | 5.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.8 | 1.6 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.8 | 3.1 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.8 | 9.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.8 | 5.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.8 | 4.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.8 | 3.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.8 | 4.7 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 0.8 | 3.1 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.8 | 0.8 | GO:0002664 | lymphocyte anergy(GO:0002249) regulation of T cell tolerance induction(GO:0002664) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.8 | 0.8 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
| 0.8 | 3.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.8 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.8 | 0.8 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.8 | 2.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.7 | 2.2 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.7 | 3.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.7 | 3.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.7 | 11.0 | GO:0010182 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.7 | 9.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.7 | 2.9 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.7 | 2.2 | GO:1901207 | regulation of heart looping(GO:1901207) |
| 0.7 | 0.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.7 | 2.9 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.7 | 2.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.7 | 5.8 | GO:0036018 | response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 0.7 | 1.4 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.7 | 2.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.7 | 4.3 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.7 | 2.2 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.7 | 5.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.7 | 3.6 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.7 | 2.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.7 | 3.5 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.7 | 2.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.7 | 2.8 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.7 | 2.1 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.7 | 1.4 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.7 | 2.1 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.7 | 0.7 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
| 0.7 | 6.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 | 2.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.7 | 2.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.7 | 2.7 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.7 | 4.0 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.7 | 4.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.7 | 2.7 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.7 | 0.7 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.7 | 2.0 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.7 | 1.3 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.7 | 2.0 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 0.7 | 4.0 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.7 | 10.5 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.7 | 11.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.7 | 0.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.7 | 3.3 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.7 | 2.6 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.7 | 2.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 0.6 | 11.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.6 | 1.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.6 | 3.9 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.6 | 1.9 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.6 | 3.2 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
| 0.6 | 1.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.6 | 2.5 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.6 | 1.9 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.6 | 1.3 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.6 | 2.5 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.6 | 1.9 | GO:0006524 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.6 | 0.6 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 0.6 | 8.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.6 | 1.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.6 | 3.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.6 | 1.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.6 | 1.8 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.6 | 4.9 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.6 | 5.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.6 | 1.8 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.6 | 1.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.6 | 1.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.6 | 2.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.6 | 1.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
| 0.6 | 2.3 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.6 | 2.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 7.6 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.6 | 7.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.6 | 3.5 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.6 | 5.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.6 | 1.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.6 | 2.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.6 | 2.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.6 | 3.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.6 | 1.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.6 | 0.6 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.6 | 1.7 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.6 | 3.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.6 | 0.6 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.6 | 3.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.6 | 1.7 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 0.6 | 1.7 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.6 | 3.9 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.6 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.6 | 7.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.6 | 6.7 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.6 | 2.8 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.6 | 7.3 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.6 | 1.7 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.6 | 7.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.6 | 1.7 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.6 | 1.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.6 | 1.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.6 | 0.6 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron import(GO:0070627) ferrous iron transmembrane transport(GO:1903874) |
| 0.5 | 1.1 | GO:0003183 | mitral valve morphogenesis(GO:0003183) |
| 0.5 | 1.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.5 | 2.2 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.5 | 0.5 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.5 | 1.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.5 | 2.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
| 0.5 | 10.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.5 | 2.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.5 | 1.1 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.5 | 3.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.5 | 6.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.5 | 3.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 | 2.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.5 | 1.6 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.5 | 3.7 | GO:0010133 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.5 | 0.5 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.5 | 4.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.5 | 3.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 | 1.0 | GO:0021772 | olfactory bulb development(GO:0021772) |
| 0.5 | 1.6 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.5 | 2.6 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
| 0.5 | 7.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 | 6.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.5 | 1.0 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.5 | 1.5 | GO:0032811 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
| 0.5 | 1.5 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.5 | 3.6 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.5 | 3.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.5 | 5.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.5 | 2.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.5 | 1.5 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.5 | 1.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.5 | 5.0 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
| 0.5 | 8.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.5 | 1.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.5 | 2.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.5 | 3.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 | 2.0 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.5 | 2.5 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.5 | 1.5 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.5 | 2.0 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.5 | 1.5 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.5 | 3.9 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.5 | 0.5 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 | 1.0 | GO:0046732 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.5 | 2.9 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.5 | 1.0 | GO:0072197 | ureter morphogenesis(GO:0072197) |
| 0.5 | 1.9 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 | 3.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.5 | 1.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.5 | 2.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.5 | 1.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.5 | 1.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.5 | 4.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.5 | 7.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.5 | 2.8 | GO:0000050 | urea cycle(GO:0000050) |
| 0.5 | 5.1 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.5 | 0.5 | GO:0032898 | neurotrophin production(GO:0032898) |
| 0.5 | 0.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.5 | 0.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.5 | 9.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.5 | 1.4 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.5 | 1.4 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.5 | 1.4 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.5 | 3.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.5 | 0.9 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.5 | 2.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.5 | 5.0 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.5 | 0.9 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
| 0.5 | 3.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.5 | 0.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.5 | 9.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.5 | 1.4 | GO:1990828 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.4 | 2.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.4 | 4.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.4 | 7.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.4 | 1.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.4 | 0.9 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.4 | 1.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 | 2.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.4 | 1.3 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.4 | 1.3 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.4 | 1.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.4 | 7.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.4 | 1.3 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.4 | 1.7 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.4 | 0.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.4 | 4.3 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.4 | 4.7 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.4 | 0.8 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.4 | 0.8 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.4 | 1.7 | GO:2000672 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.4 | 2.1 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.4 | 1.6 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.4 | 1.6 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.4 | 0.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.4 | 1.6 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.4 | 9.4 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.4 | 2.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine diphosphate metabolic process(GO:0042357) |
| 0.4 | 3.3 | GO:0045007 | depurination(GO:0045007) |
| 0.4 | 2.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 | 4.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.4 | 1.6 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 0.4 | 4.5 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.4 | 2.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 | 1.6 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.4 | 1.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.4 | 0.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.4 | 0.4 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.4 | 5.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.4 | 1.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.4 | 3.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.4 | 4.8 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.4 | 3.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.4 | 1.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.4 | 0.4 | GO:0002856 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.4 | 3.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.4 | 16.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.4 | 0.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.4 | 1.9 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.4 | 1.9 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.4 | 1.2 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.4 | 4.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 | 3.8 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.4 | 6.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.4 | 2.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.4 | 1.5 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.4 | 1.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.4 | 1.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 0.4 | 0.8 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.4 | 3.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.4 | 1.5 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.4 | 4.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.4 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 3.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.4 | 1.9 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
| 0.4 | 0.4 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.4 | 3.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.4 | 1.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.4 | 0.7 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.4 | 2.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.4 | 1.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.4 | 1.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.4 | 1.1 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.4 | 1.1 | GO:0061743 | motor learning(GO:0061743) |
| 0.4 | 0.7 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
| 0.4 | 1.8 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.4 | 0.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 | 0.7 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.4 | 19.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.4 | 1.5 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.4 | 1.5 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.4 | 4.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.4 | 1.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.4 | 1.1 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 0.4 | 2.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.4 | 1.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.4 | 4.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.4 | 0.7 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.4 | 0.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.4 | 3.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.4 | 0.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.4 | 1.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 | 8.5 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.4 | 3.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.4 | 2.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.4 | 1.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 | 2.1 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.3 | 1.4 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.3 | 0.3 | GO:0043132 | NAD transport(GO:0043132) |
| 0.3 | 4.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 | 9.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 | 2.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 | 4.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.3 | 1.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.3 | 0.7 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.3 | 0.3 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.3 | 1.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.3 | 2.4 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.3 | 0.7 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.3 | 1.7 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.3 | 2.7 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.3 | 2.4 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.3 | 0.7 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.3 | 2.4 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.3 | 4.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.3 | 0.7 | GO:0048627 | myoblast development(GO:0048627) |
| 0.3 | 1.7 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.3 | 2.4 | GO:0019075 | virus maturation(GO:0019075) |
| 0.3 | 2.7 | GO:1904385 | cellular response to angiotensin(GO:1904385) |
| 0.3 | 7.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 2.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.3 | 1.0 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.3 | 9.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.3 | 1.7 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 | 1.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.3 | 0.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.3 | 10.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.3 | 3.6 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.3 | 1.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.3 | 0.3 | GO:0009566 | fertilization(GO:0009566) |
| 0.3 | 1.6 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
| 0.3 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.3 | 2.9 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.3 | 0.3 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
| 0.3 | 2.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.3 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.3 | 1.0 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.3 | 1.0 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.3 | 6.4 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.3 | 1.9 | GO:0043627 | response to estrogen(GO:0043627) |
| 0.3 | 3.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.3 | 1.9 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.3 | 0.9 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.3 | 2.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.3 | 0.9 | GO:0048243 | norepinephrine secretion(GO:0048243) |
| 0.3 | 0.3 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.3 | 0.6 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.3 | 1.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.3 | 1.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.3 | 1.2 | GO:0060023 | soft palate development(GO:0060023) |
| 0.3 | 2.2 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.3 | 9.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.3 | 1.2 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.3 | 22.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.3 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.3 | 0.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.3 | 0.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.3 | 5.6 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.3 | 4.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 1.2 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.3 | 2.2 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.3 | 11.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.3 | 0.9 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.3 | 6.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.3 | 4.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.3 | 3.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 | 0.9 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.3 | 0.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.3 | 0.3 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.3 | 3.9 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.3 | 2.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.3 | 0.9 | GO:0035566 | regulation of metanephros size(GO:0035566) |
| 0.3 | 1.5 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.3 | 4.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 | 0.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.3 | 0.3 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.3 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
| 0.3 | 0.6 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.3 | 0.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
| 0.3 | 2.4 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.3 | 2.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.3 | 2.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 | 2.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 | 1.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.3 | 1.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.3 | 0.6 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
| 0.3 | 0.9 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.3 | 0.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.3 | 0.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.3 | 0.9 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.3 | 1.2 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
| 0.3 | 0.6 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.3 | 0.6 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.3 | 1.2 | GO:0061744 | motor behavior(GO:0061744) |
| 0.3 | 1.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 | 2.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 | 0.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.3 | 0.9 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.3 | 4.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 | 0.9 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.3 | 0.9 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.3 | 1.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.3 | 10.9 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.3 | 0.9 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.3 | 0.6 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.3 | 2.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.3 | 6.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.3 | 0.6 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.3 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.3 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.3 | 0.6 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.3 | 0.3 | GO:0043586 | tongue development(GO:0043586) |
| 0.3 | 1.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.3 | 0.8 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.3 | 1.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 | 3.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 0.3 | 1.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.3 | 0.8 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.3 | 1.7 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.3 | 1.1 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.3 | 1.1 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.3 | 0.6 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.3 | 0.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 | 1.9 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.3 | 0.3 | GO:0072190 | ureter urothelium development(GO:0072190) |
| 0.3 | 0.5 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.3 | 6.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 1.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 | 2.7 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.3 | 1.9 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.3 | 0.8 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 | 0.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.3 | 2.4 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.3 | 0.3 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
| 0.3 | 0.8 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.3 | 2.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 1.3 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.3 | 1.6 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
| 0.3 | 0.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.3 | 0.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.3 | 5.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.3 | 1.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.3 | 0.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.3 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.3 | 1.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.3 | 1.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.3 | 0.5 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.3 | 8.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.3 | 0.5 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.3 | 0.8 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 4.2 | GO:0007620 | copulation(GO:0007620) |
| 0.3 | 1.8 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.3 | 1.3 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.3 | 0.5 | GO:0097531 | mast cell migration(GO:0097531) |
| 0.3 | 1.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.3 | 0.3 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.3 | 1.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.3 | 8.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.3 | 2.9 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.3 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.3 | 4.7 | GO:0046697 | decidualization(GO:0046697) |
| 0.3 | 3.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.3 | 2.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.3 | 12.1 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.3 | 2.0 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.3 | 0.3 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
| 0.3 | 0.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.3 | 1.0 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.3 | 1.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 | 1.3 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.3 | 2.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 | 1.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 | 1.3 | GO:0033605 | positive regulation of dopamine secretion(GO:0033603) positive regulation of catecholamine secretion(GO:0033605) |
| 0.3 | 2.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.3 | 2.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.2 | 2.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.2 | 0.7 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.2 | 2.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 | 1.2 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.2 | 11.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 | 4.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.2 | 5.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 2.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.2 | 3.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.2 | 2.9 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 1.0 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 | 3.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 2.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.2 | 1.0 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.2 | 0.7 | GO:0048663 | neuron fate commitment(GO:0048663) |
| 0.2 | 0.2 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.2 | 1.7 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 0.2 | 4.6 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.2 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 1.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.2 | 1.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.2 | 0.5 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 0.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.2 | 0.7 | GO:0060078 | regulation of postsynaptic membrane potential(GO:0060078) |
| 0.2 | 0.5 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 | 1.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.2 | 0.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.2 | 2.2 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.2 | 2.9 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.2 | 2.6 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 1.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.2 | 2.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 3.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 | 5.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.2 | 1.2 | GO:0048749 | compound eye development(GO:0048749) |
| 0.2 | 0.7 | GO:0035936 | testosterone secretion(GO:0035936) regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.2 | 0.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.2 | 1.2 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 | 1.6 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.2 | 0.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.2 | 0.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.2 | 3.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 0.5 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 2.3 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 | 1.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
| 0.2 | 0.2 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.2 | 1.2 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.2 | 2.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 | 0.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.2 | 0.7 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.2 | 1.6 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 | 2.3 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.2 | 3.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.2 | 1.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.2 | 1.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 | 1.1 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 | 1.1 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
| 0.2 | 0.2 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.2 | 1.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 1.3 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.2 | 5.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.2 | 1.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 | 4.4 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.2 | 1.3 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.2 | 1.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 | 2.0 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.2 | 2.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 | 1.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.2 | 0.9 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.2 | 4.6 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.2 | 0.9 | GO:0019098 | reproductive behavior(GO:0019098) |
| 0.2 | 1.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.2 | 2.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 0.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.2 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.2 | 0.7 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.2 | 0.9 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.2 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.2 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.2 | 0.4 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.2 | 1.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
| 0.2 | 0.2 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.2 | 2.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 1.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 | 1.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.2 | 0.9 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.2 | 0.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 | 0.9 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 | 0.4 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 0.2 | 1.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.2 | 1.9 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.2 | 1.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.2 | 1.1 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.2 | 2.5 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
| 0.2 | 2.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 1.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 0.6 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.2 | 1.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.2 | 0.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.2 | 0.2 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 | 0.6 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.2 | 0.4 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 | 1.0 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
| 0.2 | 1.5 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.2 | 0.4 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.2 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.2 | 1.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 | 0.8 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 3.9 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.2 | 1.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.2 | 0.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 | 2.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.2 | 1.2 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.2 | 0.2 | GO:0098810 | neurotransmitter reuptake(GO:0098810) |
| 0.2 | 1.0 | GO:0046078 | dUMP metabolic process(GO:0046078) |
| 0.2 | 6.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 3.7 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 1.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.2 | 0.2 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 | 2.0 | GO:0009583 | phototransduction(GO:0007602) detection of light stimulus(GO:0009583) |
| 0.2 | 0.8 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.2 | 4.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 32.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 | 0.2 | GO:0035038 | female pronucleus assembly(GO:0035038) |
| 0.2 | 0.6 | GO:1904529 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.2 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 | 2.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.2 | 2.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 | 3.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.2 | 0.8 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
| 0.2 | 6.2 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
| 0.2 | 2.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.2 | 4.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 | 1.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.2 | 0.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.2 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 1.8 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 | 0.4 | GO:2000647 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of stem cell proliferation(GO:2000647) |
| 0.2 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 0.6 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.2 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 7.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.2 | 0.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.2 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.2 | 0.6 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.2 | 0.4 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.2 | 1.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
| 0.2 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 | 1.2 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 | 2.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.2 | 1.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 8.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.2 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 | 1.9 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
| 0.2 | 0.2 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 | 0.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 2.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.2 | 0.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 | 0.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.2 | 0.6 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 | 1.9 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.2 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.2 | 0.7 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.2 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.2 | 1.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 | 0.6 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.2 | 0.9 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.2 | 0.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.2 | 1.6 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 | 0.7 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
| 0.2 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.2 | 0.7 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.2 | 1.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.2 | 1.2 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 | 0.4 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.2 | 0.7 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.2 | 6.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 | 3.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.2 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.2 | 4.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.2 | 1.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 | 1.6 | GO:0051593 | response to folic acid(GO:0051593) |
| 0.2 | 2.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.2 | 0.5 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 | 2.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.2 | 4.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 0.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 | 0.2 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 | 1.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.2 | 3.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 | 0.5 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.2 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.2 | 1.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 0.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.2 | 1.2 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.2 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.2 | 0.7 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 | 0.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 | 0.8 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 | 1.4 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.2 | 2.4 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.2 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 | 1.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.2 | 0.8 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 | 2.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 | 1.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.2 | 20.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.2 | 2.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
| 0.2 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.2 | 0.7 | GO:0098582 | innate vocalization behavior(GO:0098582) |
| 0.2 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.2 | 0.2 | GO:0032329 | serine transport(GO:0032329) |
| 0.2 | 0.2 | GO:0060384 | innervation(GO:0060384) |
| 0.2 | 0.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.2 | 0.7 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.2 | 2.7 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.2 | 1.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 0.2 | 1.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 3.8 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 | 4.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 | 0.8 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 1.5 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 | 3.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.2 | 1.6 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.2 | 0.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.2 | 0.8 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 1.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.2 | 0.6 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.2 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.2 | 2.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.2 | 4.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.2 | 3.7 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 1.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 1.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 | 3.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.2 | 2.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 0.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.2 | 0.6 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 | 2.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 | 1.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.2 | 0.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.2 | 1.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 0.6 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.2 | 0.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.2 | 1.5 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.2 | 0.9 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.2 | 2.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.2 | 0.9 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 | 0.5 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 1.8 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.2 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 | 0.5 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.2 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.2 | 0.3 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.1 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 1.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 2.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.3 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.1 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 0.3 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
| 0.1 | 1.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 3.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 | 0.3 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 3.6 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 | 1.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 | 1.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.1 | 1.0 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 | 0.4 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
| 0.1 | 4.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.1 | 1.0 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 | 7.3 | GO:0006414 | translational elongation(GO:0006414) |
| 0.1 | 0.3 | GO:1990834 | response to odorant(GO:1990834) |
| 0.1 | 2.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 0.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.1 | 0.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.1 | 2.1 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.4 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.6 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 13.0 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 | 0.7 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 | 0.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 0.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.1 | 0.3 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
| 0.1 | 0.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 1.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 0.4 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.1 | 0.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.1 | 1.1 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 | 0.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
| 0.1 | 2.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 0.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 2.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.1 | 0.1 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
| 0.1 | 0.7 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.1 | 0.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 2.1 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 2.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 | 3.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.6 | GO:0001659 | temperature homeostasis(GO:0001659) |
| 0.1 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 2.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.9 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 | 0.6 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
| 0.1 | 0.8 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 | 0.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.1 | 1.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 | 0.5 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.1 | 0.6 | GO:0021557 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.1 | 0.4 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 | 0.1 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
| 0.1 | 1.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 0.4 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.1 | 1.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.1 | 0.1 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
| 0.1 | 1.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.1 | 0.2 | GO:1901258 | granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.1 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 4.6 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 1.6 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.1 | 0.2 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 | 0.9 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 | 0.9 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 2.4 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.1 | 3.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 0.6 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 | 0.5 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.1 | 1.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.1 | 2.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.1 | 2.7 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.2 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
| 0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 0.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.1 | 4.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 0.7 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 | 0.3 | GO:1903988 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.1 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.1 | 0.6 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 | 0.3 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 6.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.1 | 0.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.1 | 2.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.1 | 0.5 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 0.1 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.1 | 0.8 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.1 | 1.9 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 | 0.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.1 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.1 | 1.2 | GO:0033280 | response to vitamin D(GO:0033280) |
| 0.1 | 0.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 | 0.4 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.1 | 0.7 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
| 0.1 | 0.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 1.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 | 2.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.8 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.1 | 1.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 | 4.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 0.1 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 0.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.1 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 0.7 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 | 0.1 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 7.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 1.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.1 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 0.5 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.1 | 0.1 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.1 | 0.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 0.7 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.1 | 1.0 | GO:0008306 | associative learning(GO:0008306) |
| 0.1 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 | 0.3 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
| 0.1 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 0.1 | GO:0008105 | asymmetric protein localization(GO:0008105) apical protein localization(GO:0045176) |
| 0.1 | 1.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 1.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 0.2 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 0.7 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 0.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 | 0.3 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 | 0.4 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 | 1.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 1.6 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 | 2.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 | 0.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 0.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.1 | 1.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 1.3 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 1.2 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 0.3 | GO:0046098 | guanine catabolic process(GO:0006147) guanine metabolic process(GO:0046098) |
| 0.1 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.1 | 0.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 1.1 | GO:0048536 | spleen development(GO:0048536) |
| 0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
| 0.1 | 0.2 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
| 0.1 | 0.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 0.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 | 0.1 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.1 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.1 | 9.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 0.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.1 | 3.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
| 0.1 | 1.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 2.4 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.3 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.1 | 0.2 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
| 0.1 | 0.3 | GO:0090260 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.1 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 0.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 0.3 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 | 0.5 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 | 1.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 0.7 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 1.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.1 | 0.5 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 | 3.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.1 | 2.8 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 2.7 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 1.7 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.1 | 0.3 | GO:0000393 | generation of catalytic spliceosome for first transesterification step(GO:0000349) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 1.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.9 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 2.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.9 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.1 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 | 0.3 | GO:0046056 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) dADP metabolic process(GO:0046056) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.1 | 0.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.1 | 6.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 5.6 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.1 | 0.3 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
| 0.1 | 0.3 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
| 0.1 | 0.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 | 1.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 1.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 | 1.0 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.1 | 0.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.1 | 0.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
| 0.1 | 1.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 | 0.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.1 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.1 | 0.1 | GO:2000981 | negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.1 | 0.3 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 | 0.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 | 0.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.1 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
| 0.1 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 1.4 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 0.5 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.1 | 1.4 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 5.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.5 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 0.2 | GO:0021546 | rhombomere development(GO:0021546) |
| 0.1 | 3.4 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.1 | 0.7 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.1 | 1.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.1 | 0.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.1 | 0.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 | 1.2 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 0.1 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
| 0.1 | 0.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 0.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 0.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.2 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
| 0.1 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.1 | 0.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.1 | 0.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.1 | 0.3 | GO:0070894 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.1 | 0.3 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 0.5 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 1.7 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 0.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 1.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 1.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.1 | 0.1 | GO:2001057 | reactive nitrogen species metabolic process(GO:2001057) |
| 0.1 | 1.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.1 | 0.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.1 | 0.3 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.1 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 | 0.6 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
| 0.1 | 0.1 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
| 0.1 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 0.1 | GO:0051284 | positive regulation of sequestering of calcium ion(GO:0051284) |
| 0.1 | 0.5 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.9 | GO:0030728 | ovulation(GO:0030728) |
| 0.1 | 6.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.3 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.1 | 0.5 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.3 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.1 | 4.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.1 | 0.3 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.1 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.1 | 0.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 | 0.4 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.1 | 0.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 0.1 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 0.1 | 2.0 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
| 0.1 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 | 0.1 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
| 0.1 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 | 2.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 1.6 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
| 0.1 | 0.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.2 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 | 0.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.1 | 0.3 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.1 | 6.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 0.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.1 | 0.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 0.1 | 0.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 | 0.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.1 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 3.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 0.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.1 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.1 | 0.1 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
| 0.1 | 0.4 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
| 0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 1.5 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.1 | 1.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.3 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.1 | 0.1 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.2 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 | 0.2 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
| 0.1 | 0.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.1 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.1 | 0.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.1 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.1 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 0.6 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.1 | 0.1 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) |
| 0.1 | 0.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.1 | 0.2 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 | 0.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
| 0.1 | 0.2 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.1 | 0.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.1 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 0.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.1 | 0.7 | GO:0048730 | hair follicle morphogenesis(GO:0031069) epidermis morphogenesis(GO:0048730) |
| 0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 | 1.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.2 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.0 | 0.0 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
| 0.0 | 0.7 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 0.1 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
| 0.0 | 1.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.0 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.0 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.0 | 0.8 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 | 0.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.0 | 0.2 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
| 0.0 | 0.2 | GO:0051610 | serotonin uptake(GO:0051610) |
| 0.0 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.0 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.0 | 0.2 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 | 0.3 | GO:0071806 | protein transmembrane transport(GO:0071806) |
| 0.0 | 0.0 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
| 0.0 | 0.3 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.0 | 0.5 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.0 | 0.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.0 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.8 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.0 | 0.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.0 | 0.9 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 | 0.3 | GO:0045061 | thymic T cell selection(GO:0045061) |
| 0.0 | 0.1 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.0 | 1.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
| 0.0 | 1.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.0 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.0 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 | 0.1 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.0 | 0.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 | 0.1 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.0 | 0.4 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
| 0.0 | 1.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 0.0 | 0.0 | GO:0072077 | renal vesicle morphogenesis(GO:0072077) |
| 0.0 | 0.2 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
| 0.0 | 0.1 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.0 | 0.1 | GO:0071389 | cellular response to mineralocorticoid stimulus(GO:0071389) |
| 0.0 | 0.2 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
| 0.0 | 0.0 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.0 | 0.0 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 | 1.3 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.0 | 0.0 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 | 0.0 | GO:0043092 | L-amino acid import(GO:0043092) |
| 0.0 | 0.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.0 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.0 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.0 | 0.1 | GO:0031643 | positive regulation of myelination(GO:0031643) positive regulation of neurological system process(GO:0031646) |
| 0.0 | 0.1 | GO:0035546 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) |
| 0.0 | 0.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.0 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.3 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
| 0.0 | 0.3 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
| 0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
| 0.0 | 0.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
| 0.0 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 | 0.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
| 0.0 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 | 0.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.0 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
| 0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 | 0.7 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
| 0.0 | 0.7 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
| 0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.0 | 0.1 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 0.0 | 2.1 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 0.0 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
| 0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.0 | 0.4 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 | 0.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.0 | 0.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.0 | 0.3 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.0 | 0.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 | 0.0 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 0.4 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.0 | 0.0 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 | 0.5 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 1.4 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.2 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.0 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.0 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 | 0.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.2 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.3 | GO:0001708 | cell fate specification(GO:0001708) |
| 0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 | 0.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.0 | 0.5 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.0 | 1.8 | GO:0032355 | response to estradiol(GO:0032355) |
| 0.0 | 0.1 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 | 0.0 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.0 | 0.0 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.0 | 0.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
| 0.0 | 0.3 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.0 | 0.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 | 0.0 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
| 0.0 | 0.0 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.0 | 0.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
| 0.0 | 0.3 | GO:0043113 | receptor clustering(GO:0043113) |
| 0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
| 0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
| 0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.0 | 0.1 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
| 0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.0 | 0.1 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.0 | 0.5 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
| 0.0 | 0.1 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 | 0.0 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
| 0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.0 | 0.4 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.0 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.0 | 0.3 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.0 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.0 | 0.0 | GO:0002865 | type IV hypersensitivity(GO:0001806) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.0 | 0.0 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 | 0.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 | 0.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 | 0.3 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.0 | 0.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.0 | 0.0 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.0 | 0.0 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.0 | 0.0 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.4 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
| 0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
| 0.0 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 | 0.0 | GO:1903010 | regulation of bone development(GO:1903010) |
| 0.0 | 0.0 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.0 | 0.0 | GO:1904587 | response to glycoprotein(GO:1904587) response to thyrotropin-releasing hormone(GO:1905225) |
| 0.0 | 0.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 | 0.1 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 0.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.0 | 0.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 | 0.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.0 | 0.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.0 | 0.0 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 | 0.9 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 0.0 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 0.0 | GO:0042116 | macrophage activation(GO:0042116) |
| 0.0 | 0.0 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.0 | 0.0 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.0 | 0.0 | GO:0007618 | mating(GO:0007618) |
| 0.0 | 0.0 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.0 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.0 | 0.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 | 0.0 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
| 0.0 | 0.0 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 | 0.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 | 0.2 | GO:0001541 | ovarian follicle development(GO:0001541) |
| 0.0 | 0.0 | GO:1901535 | regulation of DNA demethylation(GO:1901535) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 13.4 | GO:0071797 | LUBAC complex(GO:0071797) |
| 1.5 | 6.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 1.3 | 5.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 1.3 | 3.9 | GO:0098855 | HCN channel complex(GO:0098855) |
| 1.3 | 11.5 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 1.3 | 3.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.2 | 3.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.2 | 8.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 1.2 | 1.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 1.2 | 8.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 1.2 | 4.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 1.1 | 10.2 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.0 | 2.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 1.0 | 3.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 1.0 | 4.0 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.9 | 4.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.9 | 4.3 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.8 | 5.9 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.8 | 4.2 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.8 | 10.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.8 | 6.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.8 | 6.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.8 | 1.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.8 | 1.6 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.8 | 6.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.8 | 3.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.7 | 5.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.7 | 3.7 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.7 | 2.2 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.7 | 5.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.7 | 2.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.7 | 5.6 | GO:0070695 | FHF complex(GO:0070695) |
| 0.7 | 2.8 | GO:0097196 | Shu complex(GO:0097196) |
| 0.7 | 2.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.7 | 2.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.7 | 3.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.6 | 12.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.6 | 2.5 | GO:1990742 | microvesicle(GO:1990742) |
| 0.6 | 5.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.6 | 5.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.6 | 4.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.6 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.6 | 1.8 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 0.6 | 0.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.6 | 5.6 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.6 | 3.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.5 | 3.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.5 | 4.9 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.5 | 0.5 | GO:0044393 | microspike(GO:0044393) |
| 0.5 | 2.1 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.5 | 9.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.5 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.5 | 3.0 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.5 | 5.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.5 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.5 | 2.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.5 | 5.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.5 | 8.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.5 | 2.3 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.5 | 2.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.4 | 1.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.4 | 0.8 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.4 | 6.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.4 | 1.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.4 | 2.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.4 | 0.8 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
| 0.4 | 4.5 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.4 | 5.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.4 | 6.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.4 | 2.8 | GO:0089701 | U2AF(GO:0089701) |
| 0.4 | 2.0 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.4 | 1.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.4 | 3.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.4 | 3.1 | GO:0043196 | varicosity(GO:0043196) |
| 0.4 | 1.2 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.4 | 1.9 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.4 | 1.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.4 | 2.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.4 | 1.2 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.4 | 0.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.4 | 6.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.4 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.4 | 3.0 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.4 | 8.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.4 | 2.9 | GO:0032009 | early phagosome(GO:0032009) |
| 0.4 | 7.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.4 | 0.7 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.4 | 2.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.4 | 3.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.4 | 16.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.3 | 9.4 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.3 | 0.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.3 | 11.0 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.3 | 1.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.3 | 1.3 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.3 | 2.3 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.3 | 1.7 | GO:0070701 | mucus layer(GO:0070701) |
| 0.3 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 1.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.3 | 5.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 2.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.3 | 3.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.3 | 1.2 | GO:0055087 | Ski complex(GO:0055087) |
| 0.3 | 1.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.3 | 2.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.3 | 1.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.3 | 2.3 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 4.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.3 | 0.6 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.3 | 22.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.3 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.3 | 2.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 5.3 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.3 | 1.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.3 | 15.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.3 | 2.5 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.3 | 1.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.3 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.3 | 3.0 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.3 | 3.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.3 | 2.4 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 3.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 11.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.3 | 3.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.3 | 2.6 | GO:0000801 | central element(GO:0000801) |
| 0.3 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 29.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.3 | 24.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.3 | 0.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.3 | 1.8 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.3 | 3.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.3 | 0.5 | GO:0044753 | amphisome(GO:0044753) |
| 0.2 | 1.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 2.0 | GO:0097361 | CIA complex(GO:0097361) |
| 0.2 | 8.9 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.2 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.2 | 0.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.2 | 12.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.2 | 1.9 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 2.6 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 0.9 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.2 | 2.3 | GO:0043235 | receptor complex(GO:0043235) |
| 0.2 | 4.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 2.7 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.2 | 8.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 2.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.2 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.2 | 1.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.2 | 1.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.2 | 26.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.2 | 1.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.2 | 3.3 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.2 | 2.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 23.1 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 4.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 2.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.2 | 1.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.2 | 2.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.2 | 1.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.2 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
| 0.2 | 1.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.2 | 1.1 | GO:0097413 | Lewy body(GO:0097413) |
| 0.2 | 0.6 | GO:0000243 | commitment complex(GO:0000243) |
| 0.2 | 2.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.2 | 0.7 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.2 | 1.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 3.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 21.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 0.5 | GO:0035101 | FACT complex(GO:0035101) |
| 0.2 | 2.5 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 0.9 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.2 | 0.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.2 | 3.8 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
| 0.2 | 1.9 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.2 | 1.4 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
| 0.2 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.2 | 2.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 2.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 13.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.2 | 25.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.2 | 0.5 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.2 | 1.0 | GO:0032021 | NELF complex(GO:0032021) |
| 0.2 | 3.3 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 1.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.2 | 0.8 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.2 | 1.1 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 1.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 0.6 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.2 | 4.9 | GO:0010369 | chromocenter(GO:0010369) |
| 0.2 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.2 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 5.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.2 | 0.8 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.2 | 1.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.2 | 0.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 13.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 3.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 2.2 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
| 0.1 | 2.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 1.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 16.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.9 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.1 | 1.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 1.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 1.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.1 | 2.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 0.6 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 9.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 3.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.1 | 0.6 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 1.4 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.1 | 1.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.1 | 0.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.1 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 2.2 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 1.7 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 0.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 0.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 1.8 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 0.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 1.1 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.5 | GO:0036025 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.1 | 1.5 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 0.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.1 | 0.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.1 | 3.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.6 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 42.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 4.2 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 1.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 9.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.1 | 3.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 6.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 2.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 1.2 | GO:0033010 | paranodal junction(GO:0033010) |
| 0.1 | 1.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 0.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.1 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 13.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 1.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 2.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 0.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.1 | 1.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 0.7 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.1 | 5.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 20.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 7.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 596.9 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.1 | 1.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.1 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 0.1 | 0.8 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 1.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.2 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.1 | 0.9 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.7 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.1 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 0.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 1.3 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 0.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.1 | 1.3 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.9 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 0.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 0.6 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.1 | 1.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.1 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
| 0.1 | 0.2 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.1 | 0.1 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 0.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 0.6 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 20.2 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 1.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.0 | 0.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 3.4 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 0.0 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.2 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.0 | 0.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.0 | 0.0 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.0 | 1.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 0.5 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 0.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 0.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.0 | 1.3 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.0 | 0.1 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.0 | 0.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.0 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.0 | 0.4 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.6 | GO:0005861 | troponin complex(GO:0005861) |
| 0.0 | 4.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 1.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
| 0.0 | 30.4 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 3.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 0.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
| 0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
| 0.0 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.0 | 0.5 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
| 0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.0 | 6.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 0.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 7.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 2.2 | 11.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 2.2 | 11.1 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 2.1 | 12.9 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 2.1 | 8.5 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 2.1 | 6.3 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 2.1 | 6.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 2.0 | 9.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.8 | 5.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.7 | 5.0 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 1.6 | 4.9 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 1.5 | 7.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.5 | 2.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 1.5 | 7.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.4 | 5.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 1.3 | 4.0 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 1.3 | 4.0 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 1.3 | 3.9 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 1.2 | 3.7 | GO:0004103 | choline kinase activity(GO:0004103) |
| 1.2 | 1.2 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 1.2 | 6.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 1.2 | 3.7 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 1.2 | 1.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.2 | 4.8 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 1.2 | 4.8 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 1.2 | 5.9 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 1.2 | 3.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 1.1 | 6.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.1 | 2.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.1 | 3.4 | GO:0070984 | SET domain binding(GO:0070984) |
| 1.1 | 4.5 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 1.1 | 2.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 1.1 | 7.7 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 1.1 | 4.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 1.1 | 13.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 1.0 | 4.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.0 | 2.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 1.0 | 9.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 1.0 | 7.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 1.0 | 12.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 1.0 | 1.0 | GO:0031208 | POZ domain binding(GO:0031208) |
| 1.0 | 6.8 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 1.0 | 6.7 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 1.0 | 6.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 1.0 | 2.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.9 | 3.7 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.9 | 4.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.9 | 3.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.9 | 2.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.9 | 2.6 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.9 | 2.6 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.9 | 4.4 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.9 | 2.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.9 | 5.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.9 | 3.4 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.9 | 0.9 | GO:0005165 | neurotrophin receptor binding(GO:0005165) neurotrophin TRK receptor binding(GO:0005167) |
| 0.8 | 10.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.8 | 4.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.8 | 1.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.8 | 7.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.8 | 2.4 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.8 | 4.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.8 | 1.6 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.8 | 4.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.8 | 6.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.8 | 6.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.8 | 5.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.8 | 4.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.7 | 2.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.7 | 1.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.7 | 0.7 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.7 | 2.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.7 | 2.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.7 | 2.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.7 | 2.9 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.7 | 3.6 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.7 | 5.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.7 | 11.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.7 | 0.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.7 | 7.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.7 | 16.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.7 | 3.5 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.7 | 5.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.7 | 2.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.7 | 2.1 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.7 | 0.7 | GO:0016531 | copper chaperone activity(GO:0016531) copper-dependent protein binding(GO:0032767) |
| 0.7 | 12.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.7 | 2.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.7 | 3.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.7 | 4.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.7 | 2.0 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.7 | 2.0 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.7 | 4.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.7 | 2.0 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.7 | 5.4 | GO:0005534 | galactose binding(GO:0005534) |
| 0.7 | 2.7 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.7 | 2.0 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.7 | 3.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.7 | 2.7 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.7 | 2.7 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.7 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.7 | 2.0 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) succinate transmembrane transporter activity(GO:0015141) |
| 0.6 | 1.9 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.6 | 3.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.6 | 1.9 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.6 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.6 | 2.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.6 | 3.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.6 | 21.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.6 | 8.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.6 | 5.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.6 | 8.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.6 | 1.8 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.6 | 1.8 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.6 | 3.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.6 | 5.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.6 | 4.2 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.6 | 2.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.6 | 2.4 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.6 | 8.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.6 | 2.9 | GO:0008430 | selenium binding(GO:0008430) |
| 0.6 | 8.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.6 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.6 | 1.7 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 0.6 | 2.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.6 | 6.9 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.6 | 1.7 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.6 | 4.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.6 | 4.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.6 | 1.7 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.6 | 3.4 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.6 | 7.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.5 | 3.8 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.5 | 1.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.5 | 6.5 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.5 | 1.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.5 | 4.3 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.5 | 1.6 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.5 | 1.6 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.5 | 2.7 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.5 | 1.6 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.5 | 2.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.5 | 1.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.5 | 0.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.5 | 1.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.5 | 1.6 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.5 | 3.6 | GO:0042806 | fucose binding(GO:0042806) |
| 0.5 | 18.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.5 | 5.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.5 | 3.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.5 | 1.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.5 | 2.0 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.5 | 1.5 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.5 | 1.5 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.5 | 3.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.5 | 3.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.5 | 1.5 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.5 | 1.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.5 | 6.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.5 | 3.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.5 | 1.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.5 | 1.4 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.5 | 1.9 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.5 | 1.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.5 | 0.9 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.5 | 0.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.5 | 4.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.5 | 3.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.5 | 1.4 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
| 0.5 | 1.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.5 | 6.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.5 | 0.5 | GO:0043121 | neurotrophin binding(GO:0043121) |
| 0.5 | 6.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.5 | 6.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.5 | 2.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.5 | 12.4 | GO:0031005 | filamin binding(GO:0031005) |
| 0.5 | 1.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.5 | 6.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.5 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.5 | 13.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.5 | 1.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.5 | 1.4 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.5 | 2.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.5 | 1.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.5 | 2.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.4 | 2.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.4 | 1.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.4 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.4 | 5.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.4 | 13.2 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.4 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.4 | 1.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.4 | 1.7 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.4 | 0.9 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.4 | 5.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.4 | 5.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.4 | 8.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.4 | 1.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.4 | 7.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.4 | 1.3 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.4 | 6.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.4 | 2.9 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.4 | 5.0 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.4 | 4.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.4 | 2.1 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.4 | 3.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.4 | 2.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.4 | 3.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 6.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.4 | 1.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.4 | 5.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.4 | 6.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.4 | 1.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.4 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.4 | 3.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.4 | 1.2 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.4 | 4.4 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.4 | 2.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.4 | 9.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.4 | 2.0 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.4 | 1.2 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.4 | 1.2 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.4 | 1.9 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.4 | 1.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.4 | 1.1 | GO:0052827 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol pentakisphosphate phosphatase activity(GO:0052827) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.4 | 7.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.4 | 4.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.4 | 1.5 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.4 | 6.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.4 | 0.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.4 | 1.1 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.4 | 2.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.4 | 1.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.4 | 1.8 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.4 | 1.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.4 | 1.8 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.4 | 8.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.4 | 1.4 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.4 | 5.1 | GO:0089720 | caspase binding(GO:0089720) |
| 0.4 | 3.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.4 | 2.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.4 | 1.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.4 | 3.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.4 | 2.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.4 | 2.1 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.4 | 1.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.3 | 0.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.3 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.3 | 1.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.3 | 1.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.3 | 4.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 1.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.3 | 6.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.3 | 7.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.3 | 1.4 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
| 0.3 | 3.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.3 | 4.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.3 | 1.0 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.3 | 1.0 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.3 | 6.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.3 | 2.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.3 | 1.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.3 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.3 | 1.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 2.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.3 | 1.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.3 | 6.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.3 | 1.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.3 | 1.0 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.3 | 2.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 1.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.3 | 0.6 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.3 | 3.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.3 | 0.6 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.3 | 2.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.3 | 2.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.3 | 1.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.3 | 1.2 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.3 | 0.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.3 | 2.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.3 | 1.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.3 | 2.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.3 | 0.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.3 | 7.6 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
| 0.3 | 2.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.3 | 1.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.3 | 1.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.3 | 14.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.3 | 4.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.3 | 1.2 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.3 | 3.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.3 | 20.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.3 | 2.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.3 | 0.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.3 | 1.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.3 | 1.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.3 | 4.3 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 0.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.3 | 1.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.3 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.3 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 4.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.3 | 2.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.3 | 4.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.3 | 2.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.3 | 1.7 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
| 0.3 | 6.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.3 | 0.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.3 | 0.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 1.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.3 | 2.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.3 | 1.1 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.3 | 2.5 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 2.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.3 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.3 | 3.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.3 | 0.8 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.3 | 1.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.3 | 0.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.3 | 1.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.3 | 2.4 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 1.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 4.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 6.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.3 | 1.6 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.3 | 1.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.3 | 2.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.3 | 2.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.3 | 1.0 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 2.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.3 | 6.7 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.3 | 1.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.3 | 3.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 1.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.3 | 0.8 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.3 | 2.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.3 | 0.8 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.3 | 0.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.3 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.3 | 3.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.2 | 2.0 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 4.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 5.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.2 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.2 | 2.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.2 | 3.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.2 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.2 | 2.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.2 | 3.4 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.2 | 2.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 6.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 1.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 11.7 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.2 | 0.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.2 | 5.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 0.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.2 | 5.1 | GO:0019841 | retinol binding(GO:0019841) |
| 0.2 | 1.6 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 0.2 | 0.7 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.2 | 2.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.2 | 1.4 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 0.7 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.2 | 2.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.2 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 2.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.2 | 2.3 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
| 0.2 | 10.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 1.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 0.9 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.2 | 3.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.2 | 3.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.2 | 6.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.2 | 7.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 0.9 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.2 | 3.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.2 | 1.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 0.9 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.2 | 6.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.2 | 0.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.2 | 0.2 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.2 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.2 | 1.1 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.2 | 2.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.2 | 1.7 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 0.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.2 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.2 | 2.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 0.6 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.2 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 0.2 | 2.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.2 | 2.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 2.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.2 | 3.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 0.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.2 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.2 | 3.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.2 | 3.2 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.2 | 0.2 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.2 | 3.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.2 | 6.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.2 | 4.1 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.2 | 1.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.2 | 21.2 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.2 | 2.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.2 | 1.0 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 2.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.2 | 7.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.2 | 1.7 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.2 | 1.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 20.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.2 | 1.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.2 | 2.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 0.7 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.2 | 0.9 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.2 | 45.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 1.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.2 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.2 | 2.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.2 | 2.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 3.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.2 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.2 | 1.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.2 | 2.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.2 | 3.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 2.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 3.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.2 | 1.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.2 | 7.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 7.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.2 | 6.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 5.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.2 | 1.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 0.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.2 | 2.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.2 | 3.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 3.4 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 1.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.2 | 1.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 0.5 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
| 0.2 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 5.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 1.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.2 | 0.5 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.2 | 4.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.2 | 3.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.2 | 5.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.2 | 4.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.2 | 0.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.2 | 2.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 1.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 0.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.2 | 2.5 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.2 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.2 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.2 | 5.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 0.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.2 | 10.8 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
| 0.2 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 0.9 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 0.2 | 2.5 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.2 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 3.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.2 | 3.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.2 | 4.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.1 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.1 | 1.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 0.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.1 | 0.6 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 2.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 2.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 0.4 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.1 | 0.9 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.1 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 1.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 4.6 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.1 | 1.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 0.6 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.1 | 0.3 | GO:0045142 | triplex DNA binding(GO:0045142) |
| 0.1 | 1.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 2.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 2.5 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 3.1 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.1 | 0.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 1.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 0.3 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 1.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 2.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 3.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 4.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 0.4 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 1.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 1.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.1 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.1 | 5.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 1.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 1.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 6.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.1 | 2.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 1.4 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 2.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 1.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 0.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.1 | 0.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 1.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.1 | 0.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.1 | 1.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 1.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.1 | 0.4 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.1 | 17.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 1.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.1 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.1 | 1.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 7.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 1.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 1.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.1 | 23.4 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 0.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.1 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 4.5 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 3.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 1.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.1 | 13.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.1 | 0.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 9.2 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 0.8 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
| 0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
| 0.1 | 0.4 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 1.0 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 0.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.1 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 4.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 2.1 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.1 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 0.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.1 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 1.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 0.3 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
| 0.1 | 0.5 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.1 | 16.8 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.1 | 0.4 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.1 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.1 | 2.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 0.9 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.1 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.8 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.1 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.3 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.1 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.1 | 11.7 | GO:0002020 | protease binding(GO:0002020) |
| 0.1 | 1.2 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.1 | 13.5 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 0.3 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.1 | 0.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.1 | 2.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.1 | 0.1 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.1 | 1.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 3.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.1 | 1.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.4 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.1 | 11.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 2.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.2 | GO:0009975 | cyclase activity(GO:0009975) |
| 0.1 | 0.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.1 | 2.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.1 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 0.2 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.1 | 0.3 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 0.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 3.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 2.9 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.1 | 0.8 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 0.8 | GO:0070990 | snRNP binding(GO:0070990) |
| 0.1 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.1 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 23.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.1 | 0.5 | GO:0030613 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 1.7 | GO:0008061 | chitin binding(GO:0008061) |
| 0.1 | 0.8 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.1 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.1 | 1.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.1 | 2.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 4.3 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.1 | 0.5 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.1 | 4.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.4 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.1 | 0.2 | GO:0015116 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
| 0.1 | 2.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 1.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.1 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 5.8 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 1.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.3 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.1 | 0.2 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.1 | 0.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 2.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.1 | 0.1 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.1 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.1 | 0.3 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.5 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.1 | 1.3 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 2.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 0.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.1 | 1.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.1 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 3.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.1 | 0.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.1 | 0.3 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.1 | 29.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 1.0 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 1.5 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.1 | 0.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.1 | 0.9 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 1.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 5.2 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 0.2 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.1 | 0.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 2.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.1 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 1.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 0.1 | 0.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.2 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.1 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.0 | 0.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.0 | 0.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.0 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.0 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.0 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.0 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 0.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.0 | 1.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.0 | 0.1 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 0.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.0 | 0.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.0 | 0.1 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
| 0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
| 0.0 | 0.5 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.0 | 0.1 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 0.1 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.0 | 0.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.0 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) |
| 0.0 | 1.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.0 | 1.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.0 | 2.2 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 2.7 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.6 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.1 | GO:0008124 | phenylalanine 4-monooxygenase activity(GO:0004505) 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.1 | GO:0042020 | interleukin-12 receptor binding(GO:0005143) interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.0 | 0.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.0 | 0.4 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
| 0.0 | 0.2 | GO:0099583 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.0 | 7.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 1.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.0 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.0 | 0.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.0 | 0.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
| 0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.0 | 1.2 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.0 | 0.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.0 | 2.6 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
| 0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.0 | 2.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.0 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.0 | 8.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.0 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.0 | 0.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.0 | 0.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.0 | 0.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.0 | 0.0 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.0 | 0.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
| 0.0 | 0.0 | GO:0048020 | CCR5 chemokine receptor binding(GO:0031730) CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 2.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.8 | 3.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.5 | 2.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.5 | 1.0 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.4 | 1.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.4 | 3.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.3 | 23.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 23.4 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.3 | 11.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.3 | 6.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 4.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.3 | 2.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.3 | 17.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 3.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 16.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 8.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 11.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.2 | 5.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 2.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 2.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 12.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 81.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 43.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 4.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.2 | 4.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 2.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.2 | 2.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 8.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 4.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 0.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 12.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.1 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 2.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 42.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 37.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.1 | 1.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 13.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 3.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 4.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 2.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 3.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 2.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 13.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 4.6 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 3.4 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 2.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 2.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 8.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 2.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 8.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 1.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 2.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 3.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.1 | 3.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 1.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 1.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 9.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 1.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 1.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 1.5 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 2.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 1.0 | PID EPO PATHWAY | EPO signaling pathway |
| 0.0 | 1.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 2.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 1.0 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
| 0.0 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 2.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.8 | 2.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.7 | 14.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.6 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.6 | 5.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.5 | 9.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.5 | 1.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.5 | 1.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.5 | 14.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 13.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.5 | 30.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.5 | 6.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.4 | 8.4 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.4 | 9.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.4 | 30.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.4 | 30.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.4 | 7.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.4 | 1.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.4 | 8.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.3 | 1.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
| 0.3 | 16.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 8.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.3 | 7.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 10.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.3 | 0.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 11.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.3 | 4.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.3 | 25.6 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.3 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.3 | 1.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.3 | 8.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.3 | 4.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.3 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.3 | 8.3 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.3 | 24.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.3 | 5.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.3 | 6.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.3 | 15.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.3 | 5.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.2 | 2.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 4.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.2 | 5.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 4.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.2 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.2 | 2.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.2 | 3.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 1.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 3.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.2 | 6.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 12.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 33.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 6.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.2 | 3.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.2 | 1.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.2 | 5.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.2 | 6.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 9.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.2 | 20.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 4.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 27.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.2 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.2 | 7.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.2 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 2.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 3.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.2 | 7.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 2.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.2 | 10.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 1.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.2 | 4.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 1.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.1 | 7.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 3.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 4.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 3.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 7.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 3.7 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 2.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 0.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 3.5 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.1 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.1 | 7.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 3.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 2.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 4.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 0.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 4.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 2.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.1 | 3.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.1 | 2.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 3.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 3.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 3.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 2.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 4.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 10.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 2.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 0.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.1 | 4.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 11.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 2.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 0.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.1 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 5.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 2.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 1.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 0.7 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.1 | 1.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 0.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.1 | 5.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 1.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 1.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.1 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 1.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 1.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 4.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.1 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 0.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 1.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 0.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 4.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 1.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 2.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.0 | 6.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 1.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.0 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.0 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.0 | 4.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.0 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.0 | 1.3 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 4.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 0.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 0.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |